More than 200 Industry Leaders to Participate, including Bruce Broussard, CEO, Humana; Andrew P. Witty, CEO, GlaxoSmithKline; Marleece Barber, M.D. Chief Medical Officer, Lockheed Martin Corporation; Jonathan Bush, President, CEO & Chairman of the Board of Directors, ; Susan Desmond-Hellman, Chancellor, The University of California, San Francisco, and former head of development of Genentech; Mikael Dolsten, President of Worldwide R&D, Pfizer; and Patrick Soon-Shiong, M.D. Board Member & CEO Healthcare Transformation Institute
Forbes Media Hosts Second Annual “Forbes Healthcare Summit 2013: Empowering the Patient Revolution” Oct. 9-10, New York, NY
Media Relations:
More than 200 prominent healthcare leaders will participate in the second annual which will be held in New York City, from October 9 – 10, 2013. This invitation-only summit, supported by Medidata, Covance, BASF, CVS Caremark, Lockheed Martin and Onyx, will bring together leaders from various disciplines in the healthcare industry for a non-partisan discussion on how consumers will drive disruption and change.
“Patients are leading the revolution in healthcare – and they’re demanding more choice and transparency and using technology to obtain the best information to be more in control of their care,” said Steve Forbes, Chairman and Editor-in-Chief of Forbes Media. “This summit will highlight how key stakeholders can work together to create actionable solutions and finance new systems that can offer better outcomes for patients.”
“The Forbes Healthcare Summit provides a unique opportunity to connect with leaders across the health ecosystem on the most pressing topics,” said Mikael Dolsten, President, Pfizer Worldwide Research & Development, who is returning this year to participate in the second annual summit. “I look forward to exploring how we can bring innovation to patients more rapidly by harnessing the power of emerging human biology, next-generation data and technology and new collaboration models.”
Attendees of the summit include executives, doctors, thinkers from hospitals, and the pharmaceuticals and insurance businesses.
“Following the success of last year’s summit, we’re reconvening top leaders in healthcare to ask how the healthcare consumer can be given a voice,” said Matthew Herper, Forbes Senior Editor, Science & Medicine. “We plan to ask tough questions like: will the healthcare exchanges from the Affordable Care Act work? How will insurance companies harness technology to change the way they do business? Are walk-in clinics a new revolution? Our goal is to continue to inspire innovative thinking to drive real change.”
For a look at the Forbes Healthcare Summit 2013 agenda, please visit: .
Forbes Media LLC, publisher of magazine and , is an authoritative source of news and information on business, investing, technology, entrepreneurship, leadership and affluent lifestyles. , a leading business website, currently reaches 47 million monthly unique visitors, according to Omniture (25 million per comscore worldwide). magazine, Forbes Asia and Forbes Europe attract a global audience of more than 5 million readers. The merges the power of print storytelling with social sharing and the web. The Company also publishes magazine, as well as 30 licensed local editions around the world.
is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud™ brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.
Covance, with headquarters in Princeton, New Jersey, is one of the world’s largest and most comprehensive drug development services companies with annual revenues greater than $2.2 billion, global operations in 60 countries, and more than 12,000 employees worldwide. Through its lead optimization, nonclinical, clinical and commercialization services, Covance has helped pharmaceutical and biotech companies develop one-third of all prescription medicines in the market today. Covance generates more safety and efficacy data for the evaluation of new prescription drugs than any other entity. The firm recognizes the importance of every data point, in every study, and of getting things right every day. Covance is proud and honored to have worked on 82 percent of the drugs approved by the U.S. Food & Drug Administration in 2012.
BASF is the world’s leading chemical company: The Chemical Company. Its portfolio ranges from chemicals, plastics, performance products and crop protection products to oil and gas. Through science and innovation, we enable our customers in nearly every industry to meet the current and future needs of society. Our products and solutions contribute to conserving resources, ensuring nutrition and improving quality of life. We have summed up this contribution in our corporate purpose: We create chemistry for a sustainable future. BASF Corporation, headquartered in Florham Park, New Jersey, is the North American affiliate of BASF SE, Ludwigshafen, Germany. BASF has more than 16,600 employees in North America, and had sales of $18.5 billion in 2012. For more information about BASF’s North American operations, visit .
CVS Caremark is dedicated to helping people on their path to better health as the largest integrated pharmacy company in the U.S. Through the company's more than 7,500 CVS/pharmacy and retail drug stores; its leading pharmacy benefit manager serving more than 60 million plan members; and its retail health clinic system with more than 600 MinuteClinic locations, it is a market leader in mail order, retail and specialty pharmacy, retail clinics, and Medicare Part D Prescription Drug Plans. As a pharmacy innovation company with an unmatched breadth of capabilities, CVS Caremark continually strives to improve health and lower costs. Find more information about how CVS Caremark is reinventing pharmacy for better health at info.cvscaremark.com.
Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company's website at . Onyx Pharmaceuticals is on Twitter. Sign up to follow our Twitter feed @OnyxPharm at .